Azenta, Inc. (AZTA)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 389 | 514 | 555 | 665 | 573 | 594 | 614 | 615 |
| Operating profit | $m | -11 | -21 | ||||||
| Net profit | $m | 65 | 111 | -429 | -14 | -165 | -56 | -123 | 16 |
| EPS reported | $ | -1.22 | -2.76 | ||||||
| Operating cashflow per share | $ | 1.58 | 0.84 | ||||||
| Capex per share | $ | 0.74 | 0.62 | ||||||
| FCF per share | $ | 0.84 | 0.22 | ||||||
| Free cash flow | $m | 38 | 10 | ||||||
| Net debt | $m | -282 | -326 | ||||||
| Book value equity | $m | 1,727 | 1,510 | ||||||
| Book value per share | $ | 37.63 | 33.35 | ||||||
| Number of shares | m | 45.9 | 45.29 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.76 | 0.87 | ||||||
| P/S LTM | x | 2.21 | 2.14 | ||||||
| P/FCF LTM | x | 34.28 | 132.96 | ||||||
| EV/EBITDA LTM | x | 21.18 | -11.85 | ||||||
| EV/Sales LTM | x | 1.93 | 2.13 | ||||||
| Earnings Yield LTM | % | -4.24% | -8.66% | ||||||
| FCF Yield | % | +2.92% | +0.75% | ||||||
| Quality | |||||||||
| ROE | % | -3.23% | -7.56% | ||||||
| ROIC | % | +2.11% | -1.01% | ||||||
| Operating margin | % | -1.90% | -3.49% | ||||||
| Gross margin | % | +45.52% | +44.05% | ||||||
| FCF/Sales | % | +6.45% | +1.61% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +3.55% | +7.04% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | +210.29% | -20.00% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.34 | 0.18 | ||||||
| Net Debt/EBITDA | x | -3.12 | 1.40 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | +4.49% | 0.00% | ||||||
| Net debt/Equity | x | -0.16 | -0.22 | ||||||
| Gross debt/equity | x | 0.06 | 0.04 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free